NCT07035418 Adolescents and Young Adults With Cancer: Their Preferred Involvement in Decision Making
| NCT ID | NCT07035418 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Adolescent Behavior |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-08-23 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2022-08-23 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this mixed-methods study is to determine Adolescent and Young Adult (AYAs) decision making preferences post cancer diagnosis using vignettes designed to assess their preferred involvement in decisions about their cancer treatment and variables associated with these treatment decision-making (TDM) preferences.
Eligibility Criteria
Inclusion Criteria: * Age (15-29 years) * Cancer diagnosis and on therapy, end-of-life or survivors (within 1 year) * Speaks English * Reads English * Cognitively and physically able to participate Exclusion Criteria: * Unable to participate in study due to developmental delay or developmental disorder
Contact & Investigator
Kimberly Pyke-Grimm
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT07035418 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 29 Years, studying Adolescent Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07035418 currently recruiting?
Yes, NCT07035418 is actively recruiting participants. Contact the research team at drswathi@stanford.edu for enrollment information.
Where is the NCT07035418 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT07035418 clinical trial?
NCT07035418 is sponsored by Stanford University. The principal investigator is Kimberly Pyke-Grimm at Stanford University. The trial plans to enroll 100 participants.